211 related articles for article (PubMed ID: 20460894)
21. Aetiopathogenesis of autoimmune hepatitis.
Vergani D; Mieli-Vergani G
World J Gastroenterol; 2008 Jun; 14(21):3306-12. PubMed ID: 18528928
[TBL] [Abstract][Full Text] [Related]
22. Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?
Christen U; Hintermann E; Holdener M; von Herrath MG
J Autoimmun; 2010 Feb; 34(1):38-44. PubMed ID: 19716269
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease?
Christen U; Hintermann E
Front Immunol; 2018; 9():163. PubMed ID: 29503645
[TBL] [Abstract][Full Text] [Related]
24. New animal models for autoimmune hepatitis.
Christen U; Hintermann E; Jaeckel E
Semin Liver Dis; 2009 Aug; 29(3):262-72. PubMed ID: 19675999
[TBL] [Abstract][Full Text] [Related]
25. Aetiopathogenesis of autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
J Autoimmun; 2010 Feb; 34(1):7-14. PubMed ID: 19766456
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome P450IID6-specific CD8 T cell immune responses mirror disease activity in autoimmune hepatitis type 2.
Longhi MS; Hussain MJ; Bogdanos DP; Quaglia A; Mieli-Vergani G; Ma Y; Vergani D
Hepatology; 2007 Aug; 46(2):472-84. PubMed ID: 17559153
[TBL] [Abstract][Full Text] [Related]
27. Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2.
Ma Y; Bogdanos DP; Hussain MJ; Underhill J; Bansal S; Longhi MS; Cheeseman P; Mieli-Vergani G; Vergani D
Gastroenterology; 2006 Mar; 130(3):868-82. PubMed ID: 16530525
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
29. Different sites of xenoantigen delivery lead to a virally induced late-onset hepatitis in mice through molecular mimicry.
Piché C; Béland K; Lapierre P; Massie B; Alvarez F
Liver Int; 2011 Oct; 31(9):1306-14. PubMed ID: 22093453
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of a mouse model of autoimmune hepatitis induced by human CYP2D6].
Chi G; Ma Q; Pei J; Feng Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Aug; 34(8):690-694. PubMed ID: 30384866
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.
Kerkar N; Choudhuri K; Ma Y; Mahmoud A; Bogdanos DP; Muratori L; Bianchi F; Williams R; Mieli-Vergani G; Vergani D
J Immunol; 2003 Feb; 170(3):1481-9. PubMed ID: 12538711
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T Cells in Autoimmune Hepatitis: Unveiling Their Roles in Mouse Models and Patients.
Wang H; Feng X; Yan W; Tian D
Front Immunol; 2020; 11():575572. PubMed ID: 33117375
[TBL] [Abstract][Full Text] [Related]
33. Animal models for autoimmune hepatitis.
Christen U; Holdener M; Hintermann E
Autoimmun Rev; 2007 Apr; 6(5):306-11. PubMed ID: 17412303
[TBL] [Abstract][Full Text] [Related]
34. LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
Komurasaki R; Imaoka S; Tada N; Okada K; Nishiguchi S; Funae Y
Drug Metab Pharmacokinet; 2010; 25(1):84-92. PubMed ID: 20208391
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune hepatitis and antigen-specific T regulatory cells: when can we send in the regulators?
Vierling JM
Hepatology; 2011 Feb; 53(2):385-8. PubMed ID: 21274860
[No Abstract] [Full Text] [Related]
36. Autoantibodies against CYP2D6 and other drug-metabolizing enzymes in autoimmune hepatitis type 2.
Mizutani T; Shinoda M; Tanaka Y; Kuno T; Hattori A; Usui T; Kuno N; Osaka T
Drug Metab Rev; 2005; 37(1):235-52. PubMed ID: 15747502
[TBL] [Abstract][Full Text] [Related]
37. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
38. Hepatic T Cell Tolerance Induction in An Inflammatory Environment.
Dywicki J; Noyan F; Misslitz AC; Hapke M; Galla M; Schlue J; Liblau RS; Taubert R; Manns MP; Jaeckel E; Hardtke-Wolenski M
Dig Dis; 2018; 36(2):156-166. PubMed ID: 29020680
[TBL] [Abstract][Full Text] [Related]
39. Immunopathogenic Mechanisms of Autoimmune Hepatitis: How Much Do We Know from Animal Models?
Christen U; Hintermann E
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27916939
[TBL] [Abstract][Full Text] [Related]
40. Adaptive immunity in autoimmune hepatitis.
Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
